IP Library Granted Patent US 9,921,214
Granted Patent B2
US 9,921,214 · App. 13/969,044 · Granted Mar 20, 2018

Method for performing a biochemical analysis, especially in outer space

Inventors: Peter Kern (Salem, DE); Herbert Backes (Saarbrucken, DE); Ulrich Kubler (Markdorf, DE)
Assignee: Airbus DS GmbH
G01N33/5306G01N33/537G01N33/54326G01N2035/00336
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,921,214
App. No.
13/969,044
Granted
Mar 20, 2018
Kind
B2
Abstract

The invention is based on a method for performing a biochemical analysis, especially in outer space, wherein at least one analyte in a sample is determined qualitatively and/or quantitatively by means of selective binding of an analyte-specific pair composed of a binding substance and a detection substance to the analyte and by labeling by a labeling substance, and wherein the sample, the binding substance, the detection substance and the labeling substance are mixed in a reaction vessel in one method step. It is proposed that the mixing be brought about by means of mixing bodies.

Claims (10)

1. A method for determining at least one analyte in a sample in outer space under conditions of reduced gravity, comprising:

a) providing, in outer space, a device that comprises a reaction vessel and a magnet unit,

wherein the reaction vessel comprises a detection region and an undetachably fixed capture antibody that binds to the at least one analyte, the undetachably fixed capture antibody located at a spatially predefined position of the reaction vessel within the detection region;

b) mixing together the sample, a detection antibody that binds the at least one analyte, and magnetic inert bodies in the reaction vessel to form a complex composed of analyte, fixed capture antibody, and detection antibody;

wherein the detection antibody carries bound to itself an enzyme capable of catalyzing a reaction that generates a detectable signal,

wherein the magnetic inert bodies consist of magnetic or magnetizable particles that do not substantially bind to the at least one analyte in the sample, to the fixed capture antibody, or to the detection antibody,

wherein the mixing is performed by motion of the magnetic inert bodies caused by application of an alternating magnetic field by the magnet unit,

c) using the magnet unit to position the magnetic inert bodies outside the detection region; and

d) determining the presence of the complex in the reaction vessel by performing optical techniques to measure the detectable signal to determine the at least one analyte in the sample.

2. The method of claim 1 , wherein in step c), the magnetic inert bodies are positioned in a corner of the reaction vessel outside of the detection region.

Assignments (3)
MERGER Recorded Jan 10, 2019
From: AIRBUS DS GMBH
To: AIRBUS DEFENCE AND SPACE GMBH
Reel/Frame 048043/0373 →
CHANGE OF NAME Recorded Apr 10, 2015
From: ASTRIUM GMBH
To: AIRBUS DS GMBH
Reel/Frame 035414/0795 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 30, 2013
From: KERN, PETER, DR.; BACKES, HERBERT; KUEBLER, ULRICH
To: ASTRIUM GMBH
Reel/Frame 031510/0801 →
Priority Claims (1)
DE 10 2012 107 651 · Aug 21, 2012 · national
Continuity (1)
Related Publication 20140057290A1 · Feb 27, 2014